Significant inverse relationship between serum undercarboxylated osteocalcin and glycemic control in maintenance hemodialysis patients (Q44552901)

4 December 2017

Significant inverse relationship between serum undercarboxylated osteocalcin and glycemic control in maintenance hemodialysis patients (English)

1 reference

4 December 2017

1 reference

S Okuno

1

1 reference

4 December 2017

E Ishimura

2

1 reference

4 December 2017

N Tsuboniwa

3

1 reference

4 December 2017

K Norimine

4

1 reference

4 December 2017

K Yamakawa

5

1 reference

4 December 2017

T Yamakawa

6

1 reference

4 December 2017

S Shoji

7

1 reference

4 December 2017

K Mori

8

1 reference

4 December 2017

Y Nishizawa

9

1 reference

4 December 2017

M Inaba

10

1 reference

4 December 2017

language of work or name

English

0 references

publication date

12 May 2012

1 reference

Osteoporosis International

4 December 2017

1 reference

4 December 2017

24

1 reference

4 December 2017

605-612

1 reference

4 December 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1007/s00198-012-2003-0

4 December 2017

0 references

cites work

Circulating biochemical markers of bone remodeling in uremic patients

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2003-0

Parathyroid hormone (PTH 1-34) regulation of rat osteocalcin gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2003-0

Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2003-0

Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2003-0

The use of biochemical markers of bone turnover in osteoporosis. Committee of Scientific Advisors of the International Osteoporosis Foundation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2003-0

Increased bone formation in osteocalcin-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2003-0

Discriminants of prevalent fractures in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2003-0

Bone and glucose metabolism: a two-way street

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2003-0

Regulation of glucose metabolism and the skeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2003-0

Endocrine regulation of energy metabolism by the skeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2003-0

Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2003-0

Bone: from a reservoir of minerals to a regulator of energy metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2003-0

The osteoblast: an insulin target cell controlling glucose homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2003-0

Relationship between osteocalcin and glucose metabolism in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2003-0

Serum osteocalcin concentrations in relation to glucose and lipid metabolism in Chinese individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2003-0

Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2003-0

Association between serum osteocalcin and markers of metabolic phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2003-0

Plasma osteocalcin is inversely related to fat mass and plasma glucose in elderly Swedish men

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2003-0

Reduced serum total osteocalcin is associated with metabolic syndrome in older men via waist circumference, hyperglycemia, and triglyceride levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2003-0

Reference intervals of serum tartrate-resistant acid phosphatase type 5b activity measured with a novel assay in Japanese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2003-0

Development of a novel fragments absorbed immunocapture enzyme assay system for tartrate-resistant acid phosphatase 5b.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2003-0

Serum levels of TRAP5b, a new bone resorption marker unaffected by renal dysfunction, as a useful marker of cortical bone loss in hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2003-0

Adiponectin is associated with changes in bone markers during glycemic control in type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2003-0

Poor glycemic control impairs the response of biochemical parameters of bone formation and resorption to exogenous 1,25-dihydroxyvitamin D3 in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2003-0

Increased bone density and decreased bone turnover, but no evident alteration of fracture susceptibility in elderly women with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2003-0

Metabolic bone disease in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2003-0

Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2003-0

Serum undercarboxylated osteocalcin levels are inversely associated with glycemic status and insulin resistance in an elderly Japanese male population: Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2003-0

The uncarboxylated form of osteocalcin is associated with improved glucose tolerance and enhanced beta-cell function in middle-aged male subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2003-0

Risk of adynamic bone disease in dialyzed patients

21 January 2018

1 reference

12 December 2020

Monoclonal antibody assay for measuring bone-specific alkaline phosphatase activity in serum.

1 reference

12 December 2020

Utility of serum tartrate-resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: independence from renal dysfunction

1 reference

12 December 2020

[Measurement of serum undercarboxylated osteocalcin by ECLIA with the "Picolumi ucOC" kit]

1 reference

12 December 2020

Serum levels of C-terminal telopeptide of type I collagen: a useful new marker of cortical bone loss in hemodialysis patients

1 reference

12 December 2020

KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).

1 reference

12 December 2020

Type 2 diabetes mellitus in nursing home patients: effects on bone turnover, bone mass, and fracture risk

1 reference

12 December 2020

Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism

1 reference

12 December 2020

10.1007/S00198-012-2003-0

Identifiers

DOI

1 reference

4 December 2017

1 reference